Literature DB >> 12706486

Inhibitory effect of the plant flavonoid galangin on rat vas deferens in vitro.

Raffaele Capasso1, Nicola Mascolo.   

Abstract

Flavonoids are phenolic compounds that are widely distributed in higher plants and therefore are ingested by humans and animals with their regular foods, but also have various pharmacological properties. In the present study we have investigated the effect of galangin, a member of the flavonol class, on the contractile response elicited by electrical field stimulation (EFS) in the rat isolated vas deferens. Galangin (10(-8)-3 x 10(-4) M) produced a concentration- dependent inhibition of the EFS-evoked contractile response, with only a minimal inhibitory effect on phenylephrine-induced contractions. The inhibitory effect of galangin was unaffected by atropine (10(-6) M) plus hexamethonium (10(-4) M), a combination of the NK(1) receptor antagonist SR 140333 (10(-7) M), the NK(2) receptor antagonist SR 48968 (10(-6) M) and the NK(3) receptor antagonist SR 142801 (10(-7) M), L-NAME (3 x 10(-4) M), naloxone (10(-6) M) or yohimbine (10(-7) M). However, the vanilloid receptor antagonist capsazepine (10(-5) M) significantly reduced the inhibitory effect of galangin. It is concluded that the galangin inhibits excitatory transmission of the rat vas deferens with a mechanism involving, at least in part, vanilloid receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706486     DOI: 10.1016/s0024-3205(03)00232-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Dose-dependent effect of galangin on fructose-mediated insulin resistance and oxidative events in rat kidney.

Authors:  Allur S Sivakumar; P Viswanathan; Carani V Anuradha
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus.

Authors:  Young-Seob Lee; Ok-Hwa Kang; Jang-Gi Choi; You-Chang Oh; Hee-Sung Chae; Jong Hak Kim; Hyun Park; Dong Hwan Sohn; Zheng-Tao Wang; Dong-Yeul Kwon
Journal:  J Microbiol       Date:  2008-07-05       Impact factor: 3.422

3.  Tibetan herbal formula Padma Digestin modulates gastrointestinal motility in vitro.

Authors:  Bruno M Balsiger; Magali Krayer; Andreas Rickenbacher; Beatrice Flogerzi; Cecile Vennos; Juergen M Gschossmann
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-02-06

4.  Assessment of Cytotoxicity Profiles of Different Phytochemicals: Comparison of Neutral Red and MTT Assays in Different Cells in Different Time Periods.

Authors:  Merve Bacanli; Hatice Gül Anlar; A Ahmet Başaran; Nursen Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

5.  Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.

Authors:  Guangxin Chen; Juxiong Liu; Liqiang Jiang; Xin Ran; Dewei He; Yuhang Li; Bingxu Huang; Wei Wang; Shoupeng Fu
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

6.  Bioflavonoid Galangin Suppresses Hypertrophic Scar Formation by the TGF-β/Smad Signaling Pathway.

Authors:  Zha Ru; Ying Hu; Shenghua Huang; Li Bai; Kun Zhang; Yue Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-04       Impact factor: 2.629

7.  In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.

Authors:  Brinda Balasubramanian; Simran Venkatraman; Kyaw Zwar Myint; Sucheewin Krobthong; Patompon Wongtrakoongate; Jittiyawadee Sripa; Panthip Rattanasinganchan; Pornphimon Metheenukul; Rutaiwan Tohtong
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

8.  Galangin Nanoparticles Protect Acetaminophen-Induced Liver Injury: A Biochemical and Histopathological Approach.

Authors:  Arezoo Mohammadi; Sohrab Kazemi; Inas Molayousefian; Marzieh Pirzadeh; Ali Akbar Moghadamnia
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

9.  Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma.

Authors:  Jingyi Cao; Hainan Wang; Feifei Chen; Jianzheng Fang; Aiming Xu; Wei Xi; Shengli Zhang; Gang Wu; Zengjun Wang
Journal:  Mol Med Rep       Date:  2016-03-24       Impact factor: 2.952

10.  Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.

Authors:  Hai-Xu Wang; Chen Tang
Journal:  Oncol Rep       Date:  2017-06-29       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.